Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, announces cUHDRS subcomponent data from the twelve-month ...
Morning Overview on MSN
Ultra-processed foods tracked to slower thinking even in people who otherwise eat well
Adults who eat more ultra-processed foods show measurably slower thinking on standardized cognitive tests, and the effect ...
CHARLOTTE, N.C. — Plasma neurofilament light chain (NfL) levels tracked closely with cognitive function in patients with relapsing multiple sclerosis (RMS), a new analysis showed, adding more evidence ...
BOSTON, June 1, 2026 /PRNewswire/ -- Skyhawk The rapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, today announced ...
On April 28th 2026, PTC Therapeutics shared new data from the long-term extension of PIVOT-HD, the Phase 2 clinical trial of votoplam, the daily pill designed to lower huntingtin (HTT) protein in ...
This nested case-control analysis used data from the ASPREE randomised trial and ASPREE-XT observational extension in Australia and the US. Community-dwelling adults aged 65 years or older without ...
In people with primary progressive multiple sclerosis (PPMS), depressive symptoms measured using the Hospital Anxiety and Depression Scale (HADS) predicted subsequent neurologic disability progression ...
Background Optical coherence tomography (OCT) inner retinal metrics reflect neurodegeneration in multiple sclerosis (MS). We explored OCT measures as biomarkers of disease severity in secondary ...
Multiple sclerosis (MS) is best known for the physical symptoms it can cause, such as numbness, weakness, spasticity, and difficulty walking. But this autoimmune disease of the central nervous system ...
TUESDAY, Dec. 17, 2024 (HealthDay News) -- β-blocker use is associated with delayed motor onset and worsening of motor symptoms with Huntington disease (HD), according to a study published online Dec.
A study has revealed the numerous effects that smoking cannabis can have on you once you're older. While a 2024 study has pointed out how much of an impact the habit can have on your health in your ...
UniQure’s gene therapy, AMT-130, has slowed disease progression by 75% during a mid-stage trial in Huntington’s disease. Image credit: eamesBot via ShutterStock.com. A Huntington’s gene therapy by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results